Table TDI-10. Characteristics of all clients treated for drug problems: demographics and primary drug at treatment in 2002 or most recent year available. Part (ii) Main drug (percentage) and of those the percent injecting it (italics)

Country		Opiates	% inj	Cocaine	% inj	Amphet amines	% inj	Ecstasy	Hallucin ogens	% inj	Cannabis	Others

Belgium	⁽¹⁾	33.2	^37.7	6	¹¹	12	⁶	1	0	⁰	15	32.8
Czech Republic	⁽²⁾	25.5	^84.1	0.1	^15.4	49.7	⁸⁵	2.4	0.5	^4.3	16.1	0.6
Denmark	⁽³⁾	46	⁴³	3	¹⁵	5	¹⁰	1	0	⁰	27	18
Germany	⁽⁴⁾	51	^na	6	na	7	^na	na	0	^na	30	6
Greece		88.9	^59.2	1.3	^18.2	0	⁰	0.4	0.1	⁰	7.3	2
Spain		59	²⁴	26	⁹	1	⁹	1	0.1	¹⁴	11	3
France	⁽⁵⁾	69.6	¹⁹	4.9	¹⁵	0.3	¹⁰	0.7	0.4	⁸	13.5	10.6
Ireland	⁽⁶⁾	67.9	^99.7	1.2	^0.1	0.6	^0.1	5.9	0.2	⁰	21.4	2.8
Italy	⁽⁷⁾	80.6	^68.9	7	¹⁷	0.2	¹	0.8	0.1	^na	9.1	2.2
Latvia	⁽⁸⁾	81.1	^95.3	0.2	⁰	1.6	^na	0	0.3	⁰	1.7	15.1
Lithuania	⁽⁹⁾	79.4	^na	0.1	^na	2.3	^na	na	0.2	^na	0.6	17.4
Luxembourg		80	⁶⁹	6	⁵⁶	0	⁰	0	0	⁰	11	3
Hungary	⁽¹¹⁾	22	⁶⁶	1	¹³	3	²²	2	1	⁷	14	57
Netherlands	⁽¹²⁾	42	¹³	35	²	2	³	1	0	⁰	17	3
Austria	⁽¹³⁾	100	¹⁰⁰	0	⁰	0	⁰	0	0	⁰	0	0
Portugal	⁽¹⁴⁾	na	^na	na	^na	na	^na	na	na	^na	na	na
Slovenia		90.4	^99.4	0.6	^0.4	0.1	⁰	0.4	0.1	⁰	7.6	0.8
Slovakia		65	^79.4	0.6	⁰	9.1	^47.4	0.4	0.4	⁰	10.5	14
Finland		34.1	⁸⁸	0.2	^na	34	⁷⁹	0.6	0.1	^na	22.9	8.2
Sweden	⁽¹⁵⁾	24	³²	2	⁰	27	³¹	2	0	⁰	30	15
United Kingdom	⁽¹⁶⁾	75	⁵⁴	6	¹⁰	3	³⁹	1	0.1	⁶	10	4.9

Notes:
		Data were not available for: Estonia, Cyprus, Malta, Poland and Norway.
		Injecting as a route of administration is not reported for cannabis.
Belgium	⁽¹⁾	Data refer only to outpatient treatment centres. Last data available refer to 1999.
Czech Republic	⁽²⁾	Data refer to all treatment centres.
Denmark	⁽³⁾	Injecting use for opiates refers only to heroin, and cocaine only to cocaine CIH. For distribution by main drug only clients attending outpatient centres.
Germany	⁽⁴⁾	Data only refer to outpatient treatment centres; information about injecting use is not available. Amphetamines also include ecstasy.
France	⁽⁵⁾	The last available data on treatment demand are reported, referring to the annual census on clients in treatment carried out in November 1999.
Ireland	⁽⁶⁾	Last data available refer to 2000.
Italy	⁽⁷⁾	Data only refer to outpatient treatment centres; information about injecting opiate use refers only to heroin, for cocaine only to cocaine CIH.
Latvia	⁽⁸⁾	Data refer only to outpatient treatment centres.
Lithuania	⁽⁹⁾	Amphetamines include all stimulants.
Hungary	⁽¹¹⁾	39% of clients are reported to use hypnotics/sedatives, 18% other substances.
Netherlands	⁽¹²⁾	Data refer only to outpatient treatment centres.
Austria	⁽¹³⁾	Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%.
Portugal	⁽¹⁴⁾	Coverage is limited and variable, with no control on double counting of clients.
Sweden	⁽¹⁵⁾	Data refer only to outpatient treatment centres.
United Kingdom	⁽¹⁶⁾	Data relate to the period from 1 April 2001 to 31 March 2002 for Scotland and Northern Ireland; for England and Wales six months data ending 30 September 2000 plus six months data ending 31 March 2001.

Sources: 2003 Reitox national reports, Standard table 3, see [Table TDI-10 Part (iii)] for details on sources.

Download

You are viewing archived content

Table TDI-10. Characteristics of all clients treated for drug problems: demographics and primary drug at treatment in 2002 or most recent year available. Part (ii) Main drug (percentage) and of those the percent injecting it (italics)